ANEST IWATA (TSE:6381) Marketable Securities: 円1,009 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6381 ANEST IWATA Corp TSE:6381
90 GF Score
Price 円1,934.00
GF Value 円1,488.23
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is ANEST IWATA Marketable Securities?

ANEST IWATA TSE:6381 -1.07% 90 Marketable Securities is 円1,009 Mil as of Mar. 2026. GuruFocus rates TSE:6381 with a GF Score™ of 90/100 and a GF Value™ of 円1,488.23 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. ANEST IWATA's Marketable Securities for the quarter that ended in Mar. 2026 was 円1,009 Mil.

ANEST IWATA's annual Marketable Securities stayed the same from Mar. 2024 (円0 Mil) to Mar. 2025 (円0 Mil) but then increased from Mar. 2025 (円0 Mil) to Mar. 2026 (円1,009 Mil).

ANEST IWATA  (TSE:6381) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

ANEST IWATA Marketable Securities Related Terms

ANEST IWATA Marketable Securities Historical Data

* Premium members only.

The historical data trend for ANEST IWATA's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ANEST IWATA Marketable Securities Chart

ANEST IWATA Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1,009.00

ANEST IWATA Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1,009.00 2,051.00
TSE:6381
90GF Score
ANEST IWATA Corp TSE:6381
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ANEST IWATA Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of 円1,009 Mil mean?
ANEST IWATA (TSE:6381) has a Marketable Securities of 円1,009 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on ANEST IWATA and its competitors.
Is ANEST IWATA's Marketable Securities too high?
ANEST IWATA's current Marketable Securities is 円1,009 Mil. Overall, ANEST IWATA has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ANEST IWATA's Marketable Securities compare to GEV and ETN?
ANEST IWATA's Marketable Securities of 円1,009 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for an Industrial Products company?
A good Marketable Securities depends on the Industrial Products industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on ANEST IWATA and its competitors. ANEST IWATA's current Marketable Securities is 円1,009 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ANEST IWATA stock overvalued right now?
Based on GuruFocus' analysis, ANEST IWATA (TSE:6381) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,488.23, compared to a current price of 円1,934.00 — trading 30% above its estimated fair value. The current Marketable Securities is 円1,009 Mil. ANEST IWATA's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For ANEST IWATA (TSE:6381), the current Marketable Securities is 円1,009 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ANEST IWATA (TSE:6381) Overvalued in 2026?

Based on GuruFocus' analysis, ANEST IWATA stock appears to be overvalued. The current stock price of 円1,934.00 is trading 30% above its estimated GF Value™ of 円1,488.23. GuruFocus considers ANEST IWATA to be Modestly Overvalued.

Key valuation signals for TSE:6381:

  • Marketable Securities: 円1,009 Mil
  • GF Value™: 円1,488.23 vs. price of 円1,934.00 (30% above fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the TSE:6381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ANEST IWATA Business Description

Address 3176, Shinyoshida-cho, Kohoku-ku, Yokohama, JPN, 223-8501
ANEST IWATA Corp manufactures and sells air compressors, pneumatic equipment and pneumatic tools. The company also manufactures and sells vacuum machinery, painting machinery, coating equipment, medical equipment, electric power supply equipment and power transmission equipment.
90GF Score

Get the complete analysis for TSE:6381

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,934.00
Price
円1,488.23
GF Value